Galaxy Biomedical Investment Co., Ltd.

シンボルマーク: 000806.SZ

SHZ

0.43

CNY

今日の市場価格

-1.1415
PER（株価収益率
0.0445
PEGレシオ
494.96M
MRK キャップ
0.00%
DIV利回り

Galaxy Biomedical Investment Co., Ltd. (000806-SZ) 財務諸表

Q: Galaxy Biomedical Investment Co., Ltd.000806.SZ 総資産とは何ですか？

Galaxy Biomedical Investment Co., Ltd. (000806.SZ) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。Galaxy Biomedical Investment Co., Ltd. (000806.SZ). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

Galaxy Biomedical Investment Co., Ltd.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
balance-sheet.row.cash-and-short-term-investments	81.1	84.6	134.8	100.4	50.7	265.9	470	569.9	312	83	120.5	203.5	347.1	211.2	114.5	146.7	88.5	234.2	336.9	561.3	620.4	165.4	90.5	80.5	40.3	9.6	1.8	1.1	1.6
balance-sheet.row.short-term-investments	3.1	-64.1	24.8	-53.9	-54.4	0	67.3	0	0	0	0	0	59	0	0	0.6	0	1.3	0	1.6	51.7	0.9	0	34	0	0	0	0	0
balance-sheet.row.net-receivables	1177.4	759.4	1146.2	696.1	1414.1	1208.3	725.7	778.2	747.4	689.6	783.9	945.8	1442.6	1747.5	1265.7	1292.5	1140.1	978.8	1060	859.5	564.5	378.5	180.2	54.9	45.3	17.2	11.2	16.6	13.4
balance-sheet.row.inventory	199.6	280.5	233.4	259.5	230.2	482.7	455.9	390.4	329.3	311.9	252.1	351.1	285.1	319.1	379.9	328.6	399.7	315.2	274.8	249.3	155.8	136.3	63.5	45.9	79.2	51.9	55.7	33.2	38.5
balance-sheet.row.other-current-assets	4.7	8	5.5	8.8	21	156.4	144.9	70	2.3	0.7	-105.3	0.5	-271.8	-360.8	0.1	0.5	0	0	119.8	-270	0.8	1	159.5	106.6	89.7	52	30.4	25	16
balance-sheet.row.total-current-assets	1462.8	1132.4	1519.9	1064.8	1716.1	2113.3	1796.5	1808.4	1390.9	1085.2	1051.1	1500.9	1803	1917	1760.1	1768.3	1628.4	1528.3	1791.5	1400.2	1341.4	681.2	493.6	287.9	254.5	130.6	99	76	69.5
balance-sheet.row.property-plant-equipment-net	253.5	285.9	274.1	283	308.8	328.7	377.8	377.4	385.5	412.1	440.5	451.5	456.2	414.7	902.5	1021.6	1383.9	1396.3	974.5	869.1	670.4	398.2	267.5	218.5	192.4	82.1	78.4	68.9	32.2
balance-sheet.row.goodwill	0	0	0	0	0	27.3	165.1	189.1	26	26	26	26	26	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	113	115.9	121.4	125	127.9	157.7	170.2	188.8	212.3	222	232.3	249.8	266	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.goodwill-and-intangible-assets	113	115.9	121.4	125	127.9	185	335.3	377.9	238.3	247.9	258.3	275.8	292	238.6	237	228.1	84.6	94.1	63	62.7	22	14.3	12.8	11.5	5.8	4.8	1.2	1.4	1.5
balance-sheet.row.long-term-investments	91.4	178.5	96.2	210.6	292.4	329.7	41.1	77.4	103.3	197.3	220.3	168.5	134.7	320.4	0	638.6	0	266.4	0	153.5	75.7	99	0	-20.5	0	0	0	0	0
balance-sheet.row.tax-assets	19.2	21.3	29.1	25.9	28.3	58.6	40.2	48.7	75.2	79.8	79.5	82.1	74.5	53.8	68.4	63	0	3.3	0	0	58.5	5.2	0	34.3	0	0	0	0	0
balance-sheet.row.other-non-current-assets	66.6	2.2	85.8	9.7	8.6	677.7	295.7	87.4	114.9	257.9	281	229.2	140.9	381	301.8	48.6	288.6	3.9	223.6	7	72.6	20.2	108.8	67.2	11.1	9	9.4	9.3	9.4
balance-sheet.row.total-non-current-assets	543.7	603.8	606.7	654.3	766	1250	1090	891.4	813.8	997.9	1059.3	1038.7	1098.3	1088.2	1509.6	1975.6	1757.1	1760.7	1261.1	1092.4	840.7	531.7	389.1	276.7	209.3	95.9	89	79.6	43.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	155.6	112.6
balance-sheet.row.account-payables	285.4	261	304.1	339.8	265.8	295.2	301	289.7	453.2	271	226.3	260	242.1	193.5	318.6	156.7	216.6	98.9	173.5	165.9	99.5	51.9	17.9	8.8	19	7.7	30.5	19.8	8.4
balance-sheet.row.short-term-debt	189.2	109.3	99.4	122.2	530.5	229	209	95	628	517.9	497	761.7	725.4	827.2	1065.6	1037	1268.3	1401.8	1062	933.8	688.7	505.7	314	65	46.3	50.7	15	13.3	4.7
balance-sheet.row.tax-payables	45.5	28.7	20.6	10	11.5	20.9	12.8	16.1	15.9	9.9	7.4	4.1	21.3	22.9	22.8	45.1	5.1	14.6	23.4	17.3	18	20.1	12.7	20.1	15.5	4.6	7.4	3.1	3
balance-sheet.row.long-term-debt-total	9.3	10.6	59	60	0	380	30	0	64	174	296.5	296.5	542.5	340.1	290.2	355.6	421.3	221.7	238.5	201.7	117.1	91.3	92.6	111.6	66.6	0	0	0	0
Deferred Revenue Non Current	36.3	41.2	44.4	52.4	52.6	58.6	56	57.2	55.7	1.5	1.5	2.8	23.6	88.7	36.4	36.5	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	569	18.1	310.2	460.8	228.8	213.2	178.1	189.9	151.7	183.4	144.3	306	226	296.7	402.4	504.1	339.6	257.3	237.7	-94.2	141.4	102.2	68.5	60.5	30.3	14.2	27.7	40.4	25.6
balance-sheet.row.total-non-current-liabilities	2205.7	1830.1	924.8	485.5	55	449.2	86.6	57.3	129.1	249	377	379	659.9	478.5	362.9	469.9	463.6	266.5	281.6	244.1	158.6	100.1	101.5	120.8	82.2	0	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	8.7	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3249.4	2631.1	2063.9	1701.1	1091.5	1186.6	774.6	631.9	1362	1221.3	1244.5	1706.6	1853.5	1795.9	2149.5	2167.8	2288.1	2024.5	1754.9	1249.6	1088.2	759.9	501.8	255.1	177.8	72.6	73.2	73.5	38.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	1099.9	699.2	699.2	699.2	699.2	699.2	699.2	699.2	635.6	635.6	418.7	349	303.4	303.4	211.6	211.6	162.8	82.2	61.2	61.2	61.2	61.2
balance-sheet.row.retained-earnings	-3534.5	-3175	-2195.6	-2253.9	-908.3	-202.7	-212.3	-225.2	-327.7	-353.8	-366	-390.1	-211.7	-137.5	-177.5	27.3	-34.6	158.2	158.9	208.2	133.2	113.8	58	53.5	65.1	40.4	18	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	1181.5	1189.5	1162.6	1178.1	1194.3	1208.7	1146.1	1138.1	447.5	490	506.4	499.3	525.7	611.1	560.6	859.2	461.8	663.1	768.4	713	643.2	119.1	102	83.9	129.4	27.8	23.8	12.9	5
balance-sheet.row.total-stockholders-equity	-1253	-885.6	66.9	24.1	1385.9	2105.9	2033.8	2012.8	819	835.5	839.7	808.5	1013.2	1172.7	1082.3	1522.1	1062.8	1240	1276.3	1224.6	1079.8	444.5	371.6	300.2	276.7	129.4	103	74.1	66.2
balance-sheet.row.total-liabilities-and-stockholders-equity	2006.5	1736.2	2126.6	1719.1	2482.1	3363.3	2886.5	2699.8	2204.8	2083.1	2110.4	2539.6	2901.4	3005.2	3269.8	3743.8	3385.5	3289	3052.6	2492.5	2182.2	1212.9	882.7	564.7	463.8	226.5	188	157.6	112.6
balance-sheet.row.minority-interest	10.2	-9.3	-4.2	-6.1	4.7	70.8	78.1	55.1	23.8	26.3	26.2	24.5	34.7	36.5	37.9	53.9	34.6	24.4	21.4	18.3	14.1	8.6	9.4	9.4	9.3	24.6	11.8	9.9	7.8
balance-sheet.row.total-equity	-1242.8	-894.9	62.7	18	1390.6	2176.7	2111.9	2067.9	842.8	861.8	865.9	832.9	1047.9	1209.3	1120.2	1576.1	1097.4	1264.4	1297.7	1242.9	1094	453	381	309.6	286	154	114.8	84	73.9
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	94.5	114.4	121	156.7	238	208.9	108.4	74	101.7	196.5	219.4	163.5	193.7	295.1	275.6	639.2	286.7	267.7	219.8	155.1	127.5	99.9	87.1	13.5	9.1	0	0	0	0
balance-sheet.row.total-debt	198.5	119.9	158.4	182.2	530.5	609	239	95	692	691.9	793.5	1058.2	1267.9	1167.3	1355.8	1392.6	1689.6	1623.5	1300.5	1135.5	805.8	597	406.6	176.6	112.8	50.7	15	13.3	4.7
balance-sheet.row.net-debt	120.5	35.3	48.4	81.8	479.8	343.1	-163.8	-474.9	380	608.8	673	854.7	979.8	956	1241.3	1246.5	1601	1390.6	963.6	575.8	237.1	432.5	316.1	130	72.5	41.1	13.2	12.2	3.1

キャッシュフロー計算書

Galaxy Biomedical Investment Co., Ltd. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	-336.6	-968.5	62.1	-1169.5	-736.3	14.6	16.4	102.6	23	12.4	25.9	-187.6	-57.6	51.4	-185.6	26.2	-180.9	10.2	143.2	127.4	79	93.4	89	49.2	30.7
cash-flows.row.depreciation-and-amortization	46.9	47.4	28.2	32.1	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-229.6	-94.8	-74.1	345.8	-140.5	-124.9	15.8	-140.4	-11.2	-8.4	250.8	214	142.8	-286.7	-228.9	-73.6	-127.6	-197.2	-319.4	1.6	-71.3	-69.8	-84.7	-76.6	-39.7
cash-flows.row.account-receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	80.9	-47.7	26.7	-22.1	89.4	-24.1	-65.5	-61.1	-17.4	-59.8	99	-66	37.1	60.8	-52.2	72.7	-97.6	-42.6	-25.4	-93.6	31	-72.9	-17.6	-6.8	-20.4
cash-flows.row.account-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-310.5	-47.1	-100.8	367.9	-229.9	-100.8	81.3	-79.3	6.2	51.4	151.8	280	105.7	-347.5	-176.7	-146.3	-30.1	-154.6	-294	95.1	-102.3	3	-67.1	-69.9	-19.3
cash-flows.row.other-non-cash-items	485.3	988.5	28.5	854.9	468.2	0.5	12	-117.4	-9.2	13.4	-19.9	181.3	118.5	-5	297.9	128.2	174.5	122.1	39.2	14.3	28.2	20.5	10	1	6.1
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.acquisitions-net	0	0.8	19.6	19.2	97.5	0.7	0.4	-166	0	0	0	11.1	0.9	396.4	27.9	0	8.5	0	181.8	264.6	3.3	0.2	0	16	99.8
cash-flows.row.purchases-of-investments	-64.7	-282.3	-220.1	-170.1	-263.8	-1142.3	-570.9	-216.9	-3	0	-65	-0.5	-105.6	-10	-13	-7.1	-0.8	-79.1	-74.8	-151.6	-145.8	-58.3	-76.2	-55.5	-2.1
cash-flows.row.sales-maturities-of-investments	77.2	315.6	212.9	202.8	372.6	795.7	199.2	285.7	138.6	63.5	23.3	118.2	22.8	243.4	95.4	142	2.3	6.9	14	194.5	56.1	3.2	52.7	30.9	5.1
cash-flows.row.other-investing-activites	1.3	2.2	-18.6	1.5	13.6	31.7	6.4	43.5	-9.2	15	15.4	14.3	69.1	26.3	15.1	127.5	15.1	3.1	0	13.2	3	0.3	2.7	0	1.8
cash-flows.row.net-cash-used-for-investing-activites	6.9	14.4	-24.8	41.9	205.9	-380.1	-403.8	-73.7	117.1	70.1	-49.6	72.1	-137.1	529.7	107.1	246.5	-95.9	-173.8	-242.5	-195.3	-340.6	-151.8	-190	-40.5	-93.2
cash-flows.row.debt-repayment	-80.9	-25	-26	-131.9	-162	-424	-105	-708	-736.8	-585.8	-873.3	-998.2	-1145.8	-884.4	-419.5	-764.9	-1233.1	-1539	-847.2	-848.7	-648.8	-379.5	-111	-44.8	-117.8
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-4.7	-4.8	-8	-17	-35.1	-15.2	-7.1	-17.6	-50.1	-52.4	-73.2	-110.4	-170.2	-112.8	-64.6	-58.6	-101.1	-86.4	-70.7	-49.9	-43.5	-48.9	-25.5	-7.2	-16.4
cash-flows.row.other-financing-activites	104	19.7	21.6	77.6	159.5	763.7	260.7	1250.7	732.8	481.4	605.6	762.4	1216.8	713	376.2	452.7	1332.3	1673.4	1012.2	908.4	1373.3	577.8	337.3	111.8	251.5
cash-flows.row.net-cash-used-provided-by-financing-activities	18.4	-10.1	-12.4	-71.3	-37.6	324.5	148.5	525.2	-54.1	-156.8	-340.9	-346.1	-99.2	-284.2	-108	-370.8	-1.9	48.1	94.4	9.8	681	149.3	200.9	59.8	117.4
cash-flows.row.effect-of-forex-changes-on-cash	0.3	-0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5
cash-flows.row.net-change-in-cash	-8.4	-23	7.5	33.9	-195.9	-122.6	-168.9	353.8	112.5	-22.7	-87.3	-17.2	15.3	50.8	-31.6	57.2	-144.3	-104	-222.8	-8.9	404.1	60.4	43.9	8.5	26.9
cash-flows.row.cash-at-end-of-period	42.2	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.5	232.9	336.9	559.7	568.6	165.4	90.5	46.6	40.3
cash-flows.row.cash-at-beginning-of-period	50.6	73.6	66.1	32.2	228.1	350.7	519.7	165.9	53.4	76.1	163.4	180.6	165.3	114.5	146.1	88.9	232.9	336.9	559.7	568.6	164.5	105	46.6	38	13.4
cash-flows.row.operating-cash-flow	-34	-27.3	44.7	63.2	-364.3	-67.1	86.4	-97.7	49.4	64	303.3	256.9	251.6	-194.7	-30.7	181.5	-46.6	21.7	-74.7	176.6	63.6	62.8	33	-10.7	2.3
cash-flows.row.capital-expenditure	-7	-22.1	-18.6	-11.4	-13.9	-65.2	-38.5	-20	-9.3	-8.4	-23.3	-59.9	-124.3	-126.4	-18.4	-15.9	-112.5	-104.6	-181.7	-251.4	-253.8	-96.9	-169.2	-16	-98
cash-flows.row.free-cash-flow	-41	-49.3	26.1	51.8	-378.3	-132.3	47.9	-117.6	40.1	55.6	279.9	197	127.3	-321.1	-49.1	165.6	-159.1	-82.9	-256.4	-74.8	-190.1	-34.1	-136.2	-26.7	-95.7

損益計算書の行

Galaxy Biomedical Investment Co., Ltd. の売上は前期比 NaN% の変化。000806.SZ の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995
income-statement-row.row.total-revenue	1528	1144.1	1106	781.4	761.3	1045.7	1204.6	832.4	801.9	784.1	957.3	957.6	976.7	1019.3	1754.9	1750.4	1015.2	987.8	1008.2	784.5	631.1	401.1	283.8	165.2	148.1	133	125.1	102.3	61.3
income-statement-row.row.cost-of-revenue	985.4	718.3	720.8	566.8	603.9	756.2	889.3	610.7	587.1	563.5	736.5	817.9	740.1	743.5	1320	1314.5	815.5	691.9	748.1	554.8	448.5	224.2	141.1	96.9	95.8	75.3	78	67.4	39.6
income-statement-row.row.gross-profit	542.6	425.8	385.2	214.6	157.3	289.5	315.3	221.7	214.8	220.6	220.8	139.7	236.6	275.9	434.9	435.9	199.8	295.9	260.1	229.7	182.6	176.9	142.8	68.3	52.3	57.6	47.2	34.9	21.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.operating-expenses	298.4	338.1	201.8	320.7	390.5	288	282.8	246.3	189.9	188.2	212.7	232.7	210	207.4	305.1	271.9	240.8	218.9	188.1	121.2	87.9	60.2	44.3	22.8	20	8.8	6.4	3.8	5
income-statement-row.row.cost-and-expenses	1283.7	1056.4	922.6	887.6	994.5	1044.2	1172.1	856.9	777	751.7	949.3	1050.6	950.1	950.9	1625.1	1586.4	1056.3	910.8	188.1	676	536.4	284.3	185.4	119.7	115.8	84.2	84.3	71.1	44.6
income-statement-row.row.interest-income	0.2	0.3	0.2	0.2	0.3	2.1	4.3	5.7	0.9	0.4	1.3	1.5	1.4	0	0.6	1.4	6	3.9	18.4	5.4	9.5	1.3	2.7	0	0	0	0	0	0
income-statement-row.row.interest-expense	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	101.3	94.5	41.9	90.8	-3.2	5.9	12.4	42.4	-2.3	3.6	12.1	9.9	21.1	3.8	6.5	5.3	-3.3	9.5	-4.8	6.6	8.2	2.4	2.3	16.1	8.2	0	4.2	3.8	3.6
income-statement-row.row.total-operating-expenses	-521.4	-992.9	-26.5	-1265.4	-468.3	5.9	12	40.8	-2.6	3.5	12	9.9	20.4	-25.4	-57.4	-8.8	-10.2	2.4	2.3	2.2	3.1	1.8	1.8	11.4	8.7	-0.1	0	-0.1	-0.1
income-statement-row.row.interest-expense	18.9	14.5	20.2	64.2	64.8	14.9	9.2	17.6	57	52.1	73.6	76.2	91.9	105	138.4	108.8	89.7	81.3	53.8	49.5	32.3	22.4	11	3.6	3.3	2.7	1.5	0.9	0.8
income-statement-row.row.depreciation-and-amortization	46.9	47.4	28.2	-210.7	44.3	42.7	42.2	57.5	46.7	46.6	46.5	49.2	47.8	45.6	85.8	100.8	87.5	86.6	62.4	33.3	27.8	18.8	18.6	15.7	5.3	2.7	-7	-7.2	-6.2
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	218.6	59.9	109.7	-106.2	-702.8	4.1	24.4	97.3	35.8	18	22.5	-201	-104.3	100.6	-110	46.8	-160.8	12.2	109.3	109.3	78.6	98.8	92.7	50.2	31.4	46.1	47.8	38.4	22.9
income-statement-row.row.income-before-tax	-302.7	-933	83.2	-1371.5	-701.5	10.1	36.4	138.1	33.2	21.5	34.5	-191.1	-83.9	75.2	-167.4	38	-171	14.6	111.6	111.5	81.7	100.7	94.5	61.6	40.2	46.1	47.8	38.3	22.9
income-statement-row.row.income-tax-expense	33.9	35.5	21.1	11.3	39.3	-3.9	19.9	35.5	10.2	9.1	8.7	-3.6	-12.1	29.9	18.2	11.8	9.9	10.4	9.1	17.3	12.9	7.3	5.5	12.3	9.5	6.9	7.2	3	3
income-statement-row.row.net-income	-336.6	-968.5	58.3	-1382.8	-706	10.2	12.9	102.5	26.1	12.2	24.1	-178.4	-74.1	39.9	-198.4	11.7	-183.4	0.9	7.1	90.1	66.8	92.5	87.6	48.3	29	26.4	28.9	26.3	18.4